These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 2905468)

  • 1. Synergistic renal effects of RS-10085, an ace inhibitor, and fenoldopam, a DA1 agonist, in the rat.
    McClelland DL; Rosenkranz RP
    Proc West Pharmacol Soc; 1988; 31():87-90. PubMed ID: 2905468
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of dopamine DA1-receptor blockade and angiotensin converting enzyme inhibition on the renal actions of fenoldopam in the anaesthetized dog.
    Clark KL; Hilditch A; Robertson MJ; Drew GM
    J Hypertens; 1991 Dec; 9(12):1143-50. PubMed ID: 1685741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of DA1 receptors by dopamine or fenoldopam increases cyclic AMP levels in the renal artery but not in the superior cervical ganglion of the rat.
    Alkadhi KA; Sabouni MH; Ansari AF; Lokhandwala MF
    J Pharmacol Exp Ther; 1986 Aug; 238(2):547-53. PubMed ID: 2874213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal effects of atrial natriuretic factor are independent of dopamine1 receptors.
    Murphy MB; Bass AS; Goldberg LI
    Am J Physiol; 1988 Sep; 255(3 Pt 2):F494-9. PubMed ID: 2970800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrarenally produced angiotensin II opposes the natriuretic action of the dopamine-1 receptor agonist fenoldopam in rats.
    Chen CJ; Apparsundaram S; Lokhandwala MF
    J Pharmacol Exp Ther; 1991 Feb; 256(2):486-91. PubMed ID: 1671595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of fenoldopam on regional vascular resistance in conscious spontaneously hypertensive rats.
    Lappe RW; Todt JA; Wendt RL
    J Pharmacol Exp Ther; 1986 Jan; 236(1):187-91. PubMed ID: 2867214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine DA1 receptor agonist, fenoldopam, reverses glycine-induced hyperfiltration in rats.
    Wang YX; Gellai M; Brooks DP
    Am J Physiol; 1992 Jun; 262(6 Pt 2):F1055-60. PubMed ID: 1352429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relative DA1-dopamine-receptor agonist and alpha-adrenoceptor antagonist activity of fenoldopam in the anesthetized dog.
    Kohli JD; Glock D; Goldberg LI
    J Cardiovasc Pharmacol; 1988 Jan; 11(1):123-6. PubMed ID: 2450250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired renal vascular response to a D1-like receptor agonist but not to an ACE inhibitor in conscious spontaneously hypertensive rats.
    de Vries PA; Navis G; de Jong PE; de Zeeuw D; Kluppel CA
    J Cardiovasc Pharmacol; 1999 Aug; 34(2):191-8. PubMed ID: 10445669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of SK&F 82526 and SK&F 83742 on the renal vascular dopamine receptor.
    Schmidt M; Imbs JL; Giesen-Crouse EM; Schwartz J
    J Pharmacol; 1985; 16(1):15-22. PubMed ID: 2582206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemodynamic characterization of YM435, a novel dopamine DA1 receptor agonist, in anesthetized dogs.
    Yatsu T; Takizawa K; Kasai-Nakagawa C; Uchida W; Tanaka A; Asano M; Honda K; Takenaka T
    J Cardiovasc Pharmacol; 1997 Mar; 29(3):382-8. PubMed ID: 9125677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular effects of selective dopamine receptor agonists and antagonists in the rat kidney.
    Schmidt M; Krieger JP; Giesen-Crouse EM; Imbs JL
    Arch Int Pharmacodyn Ther; 1987 Apr; 286(2):195-205. PubMed ID: 2954515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective antagonism of renal hemodynamic changes induced by dopamine, DPDA, fenoldopam and quinpirole in the rat.
    Rosenkranz RP; McClelland DL
    Proc West Pharmacol Soc; 1987; 30():25-36. PubMed ID: 2888129
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of the effects of the novel inotropic agent, ibopamine, with epinine, dopamine and fenoldopam on renal vascular dopamine receptors in the anesthetized dog.
    Nichols AJ; Smith JM; Shebuski RJ; Ruffolo RR
    J Pharmacol Exp Ther; 1987 Aug; 242(2):573-8. PubMed ID: 2886644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increase in plasma renin activity evoked by fenoldopam in dogs is directly mediated by dopamine1 receptor stimulation.
    Montier F; Katchadourian P; Pratz J; Cavero I
    J Cardiovasc Pharmacol; 1989 May; 13(5):739-47. PubMed ID: 2472522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the hypotensive action of dopamine receptor agonists fenoldopam and quinpirole in anaesthetized rats.
    Sengupta S; Lokhandwala MF
    J Auton Pharmacol; 1985 Dec; 5(4):289-94. PubMed ID: 2869041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular and renal hemodynamic effects of intravenous infusions of the selective DA1 agonist, fenoldopam, used alone or in combination with dopamine and dobutamine.
    Lass NA; Glock D; Goldberg LI
    Circulation; 1988 Nov; 78(5 Pt 1):1310-5. PubMed ID: 2902941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of oral fenoldopam (SKF 82526-J), a peripheral dopamine receptor agonist, on blood pressure and renal function in normal man.
    Harvey JN; Worth DP; Brown J; Lee MR
    Br J Clin Pharmacol; 1985 Jan; 19(1):21-7. PubMed ID: 2858215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypotensive and regional hemodynamic effects of the dopamine receptor agonist SK & F 85174 in the anesthetized rat.
    Van der Niepen P; Schoors DF; Dupont AG
    Arch Int Pharmacodyn Ther; 1991; 313():98-107. PubMed ID: 1687774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological and toxicological studies of the new angiotensin converting enzyme inhibitor moexipril hydrochloride.
    Friehe H; Ney P
    Arzneimittelforschung; 1997 Feb; 47(2):132-44. PubMed ID: 9079232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.